Filing Details
- Accession Number:
- 0001127602-19-016956
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-02 16:30:28
- Reporting Period:
- 2019-05-01
- Accepted Time:
- 2019-05-02 16:30:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1672709 | Michel Vounatsos | Biogen Inc. 225 Binney St. Cambridge MA 02142 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-01 | 4,351 | $231.48 | 21,007 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This represents the weighted average price for shares purchased at a range between $231.47 (low) and $232.06 (high).
- Full information regarding the number of shares purchased at each separate price will be provided to the SEC staff, the issuer or any security holder of the issuer, upon their request.
- Includes 82.051 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2019.
Billionaire Hedge Funds
